| | Identification | Back Directory |  | [Name] 
 ML335
 |  | [CAS] 
 825658-06-8
 |  | [Synonyms] 
 TREK-1/2 Activator
 ML335; ML-335; ML 335; TREK-1/2 ACTIVATOR
 Benzamide, N-[(2,4-dichlorophenyl)methyl]-4-[(methylsulfonyl)amino]-
 |  | [Molecular Formula] 
 C15H14Cl2N2O3S
 |  | [MDL Number] 
 MFCD06003481
 |  | [MOL File] 
 825658-06-8.mol
 |  | [Molecular Weight] 
 373.25
 | 
 | Chemical Properties | Back Directory |  | [storage temp. ] 
 -20°
 |  | [solubility ] 
 Soluble in DMSO (up to 50 mg/ml) or in Ethanol (up to 20 mg/ml with warming).
 |  | [form ] 
 solid
 |  | [color ] 
 White
 |  | [Stability:] 
 Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 2 months.
 | 
 | Hazard Information | Back Directory |  | [Description] 
 Two-pore domain potassium (K2P) channels of the TREK subfamily regulate neuronal excitability, influence pain, temperature perception and responses to anesthetics. ML-335 (825658-06-8) is a novel, selective TREK-1,2 activator with EC50s of 14.3 and 5.2 μM.1?It represents an important new pharmacological tool for studying the physiology of TREK channels.
 |  | [Uses] 
 ML335, is a selective activator of both TREK-1 and TREK-2.
 |  | [storage] 
 Store at +4°C
 |  | [References] 
 1) Lolicato?et al.?(2017),?K2P2.1 (TREK-1)-activator complexes reveal a cryptic selectivity filter binding site; Nature,?547?364
 | 
 |  |